FDA Action On MDMA Gives New Hope To Researchers And Victims Of PTSD
The Food and Drug Administration recently announced a change of status of the psychedelic compound MDMA for the treatment of post-traumatic stress disorder (PTSD), a move that some researchers see as the first step towards a psychedelic cultural renaissance.
